LICENSE AGREEMENTLicense Agreement • February 23rd, 2017 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”), is made as of February 21, 2017 (the “Effective Date”), by and among Eyegate Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (“Eyegate Pharmaceuticals”), EyeGate Pharma S.A.S., a French corporation and wholly owned subsidiary of Eyegate Pharmaceuticals (“EyeGate Pharma” and, collectively with Eyegate Pharmaceuticals, “Eyegate”) and Valeant Pharmaceuticals Ireland, a company duly formed and validly existing under the laws of the Republic of Ireland (“Valeant”).
